Science Explorer Back to mapMap
Discussion
Nonprofit · Danbury · United States

National Organization for Rare Disorders

rarediseases.orgROR OpenAlex
Research works
37
▼ 8% vs 2018-21
Citations
736
19.8 per fractional work
Top-10% rate
9.2%
all institutions 10.0%
Open access
40%
world 40%
International
19%
world 18%
National Organization for Rare Disorders

Not ranked overall: National Organization for Rare Disorders is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does National Organization for Rare Disorders work in?

In all years, 42% of research at National Organization for Rare Disorders is in Life Sciences, 37% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (37%), Medicine (31%), Economics, Econometrics and Finance (15%). It does 2.2× the world's share of Life Sciences.

Life Sciences: 16 fractional works · 41.7% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 36.7% of its workGenetics: 10 fractional works · 27.7% of its workMolecular Biology: 2 fractional works · 5.8% of its workCell Biology: 1 fractional works · 1.8% of its workCancer Research: 0 fractional works · 1.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.7% of its workPharmacology: 1 fractional works · 2.7% of its workImmunology and Microbiology: 1 fractional works · 1.6% of its workImmunology: 1 fractional works · 1.6% of its workNeuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.5% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workHealth Sciences: 14 fractional works · 36.5% of its workMedicine: 11 fractional works · 30.6% of its workPublic Health, Environmental and Occupational Health: 3 fractional works · 9.0% of its workGenetics: 1 fractional works · 3.6% of its workPsychiatry and Mental health: 1 fractional works · 2.9% of its workPathology and Forensic Medicine: 1 fractional works · 2.7% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.6% of its workPhysiology: 1 fractional works · 1.8% of its workRheumatology: 1 fractional works · 1.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.2% of its workHematology: 0 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.0% of its workEmergency Medicine: 0 fractional works · 0.9% of its workFamily Practice: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.5% of its workOncology: 0 fractional works · 0.5% of its workEpidemiology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 2 fractional works · 5.9% of its workGeneral Health Professions: 2 fractional works · 5.9% of its workSocial Sciences: 8 fractional works · 20.1% of its workEconomics, Econometrics and Finance: 6 fractional works · 15.1% of its workEconomics and Econometrics: 6 fractional works · 15.1% of its workPsychology: 1 fractional works · 2.9% of its workExperimental and Cognitive Psychology: 1 fractional works · 2.7% of its workClinical Psychology: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 1 fractional works · 1.9% of its workManagement of Technology and Innovation: 1 fractional works · 1.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.3% of its workPhysical Sciences: 1 fractional works · 1.7% of its workEngineering: 0 fractional works · 0.8% of its workBiomedical Engineering: 0 fractional works · 0.5% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnvironmental Science: 0 fractional works · 0.7% of its workGlobal and Planetary Change: 0 fractional works · 0.7% of its workComputer Science: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.1% of its workALL ITS WORKNationalOrganization for…37fractional works, all years
Life Sciences42%Physical Sciences2%Health Sciences37%Social Sciences20%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1436.7%
    2. Pharmacology, Toxicology and Pharmaceutics12.7%
    3. Immunology and Microbiology11.6%
    4. Neuroscience00.8%
    1. Medicine1130.6%
    2. Health Professions25.9%
    1. Economics, Econometrics and Finance615.1%
    2. Psychology12.9%
    3. Business, Management and Accounting11.9%
    4. Social Sciences00.3%
    1. Engineering00.8%
    2. Environmental Science00.7%
    3. Computer Science00.1%
    4. Mathematics00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.09× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.85× its world share, 0 worksImmunology and Micro…Neuroscience: 0.81× its world share, 0 worksNeuroscienceComputer Science: 0.05× its world share, 0 worksComputer ScienceEngineering: 0.19× its world share, 0 worksEngineeringEnvironmental Science: 0.60× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.89× its world share, 0 worksHealth ProfessionsMedicine: 2.32× its world share, 4 worksMedicineEconomics, Econometrics and Finance: 8.42× its world share, 2 worksEconomics, Econometr…Psychology: 0.31× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 8.4×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Economics, Econometrics and Finance8.42×2 works
  2. Immunology and Microbiology4.85×0 works
  3. Biochemistry, Genetics and Molecular Biology4.09×2 works
  4. Medicine2.32×4 works
  5. Health Professions0.89×0 works
  6. Neuroscience0.81×0 works
  7. Environmental Science0.60×0 works
  8. Psychology0.31×0 works
  9. Engineering0.19×0 works
  10. Computer Science0.05×0 works

Who are the top researchers at National Organization for Rare Disorders?

Ranked on the quality score, Vanessa M. Boulanger lead among researchers whose main affiliation is National Organization for Rare Disorders.

  1. 1 Vanessa M. Boulanger United States · #1,460,347 worldwide 522 citations · 19 works
All ranked researchers at National Organization for Rare Disorders

What are the most cited papers from National Organization for Rare Disorders?

The most cited paper from National Organization for Rare Disorders is "Clinical research for rare disease: Opportunities, challenges, and solutions" (Robert C. Griggs, Mark L. Batshaw, Mary Dunkle et al., 2008), with 413 citations. Next come "From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients" (194) and "The National Organization for Rare Disorders (NORD)" (182).

Most cited papers
#PaperReleasedCitations
1 Clinical research for rare disease: Opportunities, challenges, and solutions Robert C. Griggs, Mark L. Batshaw, Mary Dunkle et al. · Molecular Genetics and Metabolism Open access 14 Nov 2008 413
2 From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients H‐G Eichler et al. · Clinical Pharmacology & Therapeutics Open access 4 Feb 2015 194
3 The National Organization for Rare Disorders (NORD) Stefanie Putkowski · NASN School Nurse 30 Nov 2009 182
4 Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges Takeya Adachi, Ayman W. El‐Hattab, Ritu Jain et al. · International Journal of Environmental Research and Public Health Open access 8 Mar 2023 172
5 Establishing Patient Registries for Rare Diseases: Rationale and Challenges Vanessa M. Boulanger, Marissa Schlemmer, Suzanne Rossov et al. · Pharmaceutical Medicine Open access 25 Mar 2020 134
All 73 most cited papers, with filters and sorting

Which keywords describe research at National Organization for Rare Disorders?

By fractional works in all years, weighted toward what it does more of than the world: Genetic Variants, Sequence Interpretation, Innovation, Pharmaceutical Industry, Cost-effectiveness Analysis, Health Utility Measures, Quality of Life and Global Collaboration.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Genetic Variants7▲ 84×1 topic
  2. Sequence Interpretation7▲ 747×1 topic
  3. Innovation4▲ 11×3 topics
  4. Pharmaceutical Industry3▲ 222×2 topics
  5. Quality of Life3▲ 6.4×3 topics
  6. Cost-effectiveness Analysis3▲ 101×1 topic
  7. Health Utility Measures3▲ 101×1 topic
  8. Global Collaboration3▲ 181×1 topic
  9. Health Biotechnology3▲ 390×1 topic
  10. Genetic Mutations2▲ 12×4 topics
  11. Drug Development Costs2▲ 246×1 topic
  12. Generic Drugs2▲ 246×1 topic
  13. Healthcare2▲ 8.2×3 topics
  14. Neuroscience2▲ 17×2 topics
  15. Clinical Trials2▲ 7.9×4 topics
  16. Primary Care2▲ 12×3 topics
  17. BRCA12▲ 161×1 topic
  18. BRCA22▲ 161×1 topic
  19. Breast Cancer2▲ 16×2 topics
  20. Precision Medicine2▲ 14×2 topics
  21. Public Health2▲ 3.2×5 topics
  22. Fragile X Syndrome1▲ 111×1 topic
  23. Rett Syndrome1▲ 111×1 topic
  24. Autoantibodies1▲ 13×4 topics
  25. Epidemiology1▼ 0.80×10 topics
  26. Genome Engineering1▲ 53×1 topic
  27. Patient Satisfaction1▲ 13×2 topics
  28. RNA-Guided1▲ 53×1 topic
  29. Rituximab1▲ 20×3 topics
  30. Conflict of Interest1▲ 201×1 topic
  31. Dance Movement Therapy1▲ 223×1 topic
  32. Empathy1▲ 20×1 topic
  33. Injury Patterns1▲ 223×1 topic
  34. Medical Education1▲ 11×1 topic
  35. NHS1▲ 132×1 topic
  36. Policy1▲ 16×1 topic
  37. Research Outcome1▲ 201×1 topic

Which research topics does National Organization for Rare Disorders publish most on?

By volume in 2022-now: Health Systems, Economic Evaluations, Quality of Life, Genomics and Rare Diseases, Pharmaceutical Economics and Policy and CRISPR and Genetic Engineering.

Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksGenomics and Rare Diseases: 1 fractional worksPharmaceutical Economics…1Pharmaceutical Economics and Policy: 1 fractional worksCRISPR and Genetic Engin…0CRISPR and Genetic Engineering: 0 fractional worksNeurogenetic and Muscular Disorders Research: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksPharmaceutical studies a…0Pharmaceutical studies and practices: 0 fractional worksCardiomyopathy and Myosin Studies: 0 fractional worksImmunodeficiency and Autoimmune Disorders: 0 fractional worksConservation, Biodiversity, and Resource Management: 0 fractional works
Economics and EconometricsGeneticsMolecular BiologyPediatrics, Perinatology and Child Health3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  2. 2 Genomics and Rare Diseases Genetics 1 works
  3. 3 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  4. 4 CRISPR and Genetic Engineering Molecular Biology 0 works
  5. 5 Neurogenetic and Muscular Disorders Research Genetics 0 works
  6. 6 Chronic Lymphocytic Leukemia Research Genetics 0 works
  7. 7 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  8. 8 Cardiomyopathy and Myosin Studies Cardiology and Cardiovascular Medicine 0 works
  9. 9 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  10. 10 Conservation, Biodiversity, and Resource Management Global and Planetary Change 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.2%not open59.8%

World: 40% of research is openly available.

with international co-authors18.6%domestic only81.4%

World: 18% is written across borders.

How has National Organization for Rare Disorders's research output changed?

Output in 2022-2025 was 8% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is National Organization for Rare Disorders as a percentage of every work published that year, 0.000028% in 2024.

still counting0.00010%0.00020%0.00030%National Organization for Rare Disorders0.000022% in 20251990200020102020

Fractional works of National Organization for Rare Disorders over all fractional works that year. How the balance of science has shifted.

Other research institutions in Danbury

All research institutions in Danbury

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about National Organization for Rare Disorders. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.